2-201491397-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001168221.2(C2CD6):​c.4944G>C​(p.Lys1648Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000163 in 1,537,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.00013 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000036 ( 0 hom. )

Consequence

C2CD6
NM_001168221.2 missense

Scores

1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.346
Variant links:
Genes affected
C2CD6 (HGNC:14438): (C2 calcium dependent domain containing 6) An autosomal recessive form of juvenile amyotrophic lateral sclerosis was originally mapped to a region of chromosome 2 that includes this gene. The encoded protein contains a calcium-dependent membrane targeting C2 domain. This domain is often found in proteins that are involved in membrane trafficking and signal transduction. [provided by RefSeq, Jun 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05663553).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C2CD6NM_001168221.2 linkc.4944G>C p.Lys1648Asn missense_variant Exon 15 of 16 ENST00000439140.6 NP_001161693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C2CD6ENST00000439140.6 linkc.4944G>C p.Lys1648Asn missense_variant Exon 15 of 16 1 NM_001168221.2 ENSP00000409937.1 Q53TS8-4
C2CD6ENST00000286195.7 linkc.1582-3495G>C intron_variant Intron 14 of 14 1 ENSP00000286195.3 Q53TS8-1
C2CD6ENST00000439802.5 linkc.*50-3495G>C intron_variant Intron 12 of 12 2 ENSP00000400672.1 Q53TS8-2
C2CD6ENST00000482942.1 linkn.101-3495G>C intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152100
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000141
AC:
2
AN:
142300
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
76096
show subpopulations
Gnomad AFR exome
AF:
0.000261
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000361
AC:
5
AN:
1384958
Hom.:
0
Cov.:
33
AF XY:
0.00000293
AC XY:
2
AN XY:
683410
show subpopulations
Gnomad4 AFR exome
AF:
0.000158
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152100
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.000459
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 06, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.4944G>C (p.K1648N) alteration is located in exon 15 (coding exon 15) of the ALS2CR11 gene. This alteration results from a G to C substitution at nucleotide position 4944, causing the lysine (K) at amino acid position 1648 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.2
DANN
Uncertain
0.98
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.40
T
M_CAP
Benign
0.0095
T
MetaRNN
Benign
0.057
T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.099
Sift
Benign
0.078
T
Sift4G
Benign
0.062
T
Vest4
0.067
MutPred
0.36
Loss of methylation at K1648 (P = 0.0011);
MVP
0.061
MPC
0.26
ClinPred
0.029
T
GERP RS
0.039
gMVP
0.0070

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1005141925; hg19: chr2-202356120; API